Anti-MYOF/ FER1L3 monoclonal antibody

Anti-MYOF/ FER1L3 antibody for FACS & in-vivo assay

Target products collectionGo to MYOF/MYOF products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0861-Ab-1/ GM-Tg-hg-MP0861-Ab-2Anti-Human MYOF monoclonal antibodyHuman
GM-Tg-rg-MP0861-Ab-1/ GM-Tg-rg-MP0861-Ab-2Anti-Rat MYOF monoclonal antibodyRat
GM-Tg-mg-MP0861-Ab-1/ GM-Tg-mg-MP0861-Ab-2Anti-Mouse MYOF monoclonal antibodyMouse
GM-Tg-cynog-MP0861-Ab-1/ GM-Tg-cynog-MP0861-Ab-2Anti-Cynomolgus/ Rhesus macaque MYOF monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0861-Ab-1/ GM-Tg-felg-MP0861-Ab-2Anti-Feline MYOF monoclonal antibodyFeline
GM-Tg-cang-MP0861-Ab-1/ GM-Tg-cang-MP0861-Ab-2Anti-Canine MYOF monoclonal antibodyCanine
GM-Tg-bovg-MP0861-Ab-1/ GM-Tg-bovg-MP0861-Ab-2Anti-Bovine MYOF monoclonal antibodyBovine
GM-Tg-equg-MP0861-Ab-1/ GM-Tg-equg-MP0861-Ab-2Anti-Equine MYOF monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0861-Ab-1/ GM-Tg-hg-MP0861-Ab-2; GM-Tg-rg-MP0861-Ab-1/ GM-Tg-rg-MP0861-Ab-2;
GM-Tg-mg-MP0861-Ab-1/ GM-Tg-mg-MP0861-Ab-2; GM-Tg-cynog-MP0861-Ab-1/ GM-Tg-cynog-MP0861-Ab-2;
GM-Tg-felg-MP0861-Ab-1/ GM-Tg-felg-MP0861-Ab-2; GM-Tg-cang-MP0861-Ab-1/ GM-Tg-cang-MP0861-Ab-2;
GM-Tg-bovg-MP0861-Ab-1/ GM-Tg-bovg-MP0861-Ab-2; GM-Tg-equg-MP0861-Ab-1/ GM-Tg-equg-MP0861-Ab-2
Products NameAnti-MYOF monoclonal antibody
Formatmab
Target NameMYOF
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MYOF benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species MYOF/ FER1L3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0861
    Target NameMYOF
    Gene ID26509,226101,309499,700922,607472,101087102,513597,100071199
    Gene Symbol and Synonyms2310004N10Rik,2310051D19Rik,E030042N20Rik,FER1L3,HAE7,MYOF,RGD1564216
    Uniprot AccessionQ9NZM1
    Uniprot Entry NameMYOF_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000138119
    Target ClassificationN/A

    The target: MYOF, gene name: MYOF, also named as FER1L3. Mutations in dysferlin, a protein associated with the plasma membrane, can cause muscle weakness that affects both proximal and distal muscles. The protein encoded by this gene is a type II membrane protein that is structurally similar to dysferlin. It is a member of the ferlin family and associates with both plasma and nuclear membranes. The protein contains C2 domains that play a role in calcium-mediated membrane fusion events, suggesting that it may be involved in membrane regeneration and repair. Two transcript variants encoding different isoforms have been found for this gene. Other possible variants have been detected, but their full-length nature has not been determined. [provided by RefSeq, Dec 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.